Page last updated: 2024-09-04

pomalidomide and Pleural Effusion, Malignant

pomalidomide has been researched along with Pleural Effusion, Malignant in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Carilli, A; Chahin, A; Comba, IY; Taj, H1
Blanchard, MJ; Fra-Fernández, S; Gorospe-Sarasúa, L; Velasco-Álvarez, D1

Other Studies

2 other study(ies) available for pomalidomide and Pleural Effusion, Malignant

ArticleYear
Pomalidomide and dexamethasone in myelomatous pleural effusion.
    BMJ case reports, 2020, Dec-10, Volume: 13, Issue:12

    Topics: Dexamethasone; Drainage; Dyspnea; Humans; Male; Middle Aged; Multiple Myeloma; Plasma Cells; Pleural Effusion, Malignant; Radiography, Thoracic; Thalidomide; Thoracentesis; Treatment Outcome

2020
Extramedullary Multiple Myeloma With Pleural Involvement: A Rare Clinical Entity.
    Archivos de bronconeumologia, 2019, Volume: 55, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Drainage; Humans; Male; Multiple Myeloma; Neoplastic Stem Cells; Plasma Cells; Pleural Effusion, Malignant; Pleurodesis; Radiotherapy, Adjuvant; Remission Induction; Talc; Thalidomide

2019